Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer

doi:10.3748/wjg.v23.i14.2519

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8348)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

570

WORD

363

HTML

4112

Figures (1-3)

232

Tables (1-3)

217

Sum=5494

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

953

Download

1900

Sum=2853

Apr 14, 2017 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (48)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Apr 14, 2017; 23(14): 2519-2526
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2519

Full Size Figure Download Figure

Figure 2 Comparison of the prevalence of each complication type between the high and low platelet-lymphocyte ratio groups.

Citation: Inaoka K, Kanda M, Uda H, Tanaka Y, Tanaka C, Kobayashi D, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer. World J Gastroenterol 2017; 23(14): 2519-2526
URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2519.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2519